Concise Review: Developing Best-Practice Models for the Therapeutic Use of Extracellular Vesicles
Recommended Citation
Reiner AT, Witwer KW, van Balkom BWM, de Beer J, Brodie C, Corteling RL, Gabrielsson S, Gimona M, Ibrahim AG, de Kleijn D, Lai CP, Lotvall J, Del Portillo HA, Reischl IG, Riazifar M, Salomon C, Tahara H, Toh WS, Wauben MHM, Yang VK, Yang Y, Yeo RWY, Yin H, Giebel B, Rohde E, and Lim SK. Concise Review: Developing Best-Practice Models for the Therapeutic Use of Extracellular Vesicles. Stem Cells Transl Med 2017; 6(8):1730-1739.
Document Type
Article
Publication Date
8-1-2017
Publication Title
Stem Cells Transl Med
Abstract
Growing interest in extracellular vesicles (EVs, including exosomes and microvesicles) as therapeutic entities, particularly in stem cell-related approaches, has underlined the need for standardization and coordination of development efforts. Members of the International Society for Extracellular Vesicles and the Society for Clinical Research and Translation of Extracellular Vesicles Singapore convened a Workshop on this topic to discuss the opportunities and challenges associated with development of EV-based therapeutics at the preclinical and clinical levels. This review outlines topic-specific action items that, if addressed, will enhance the development of best-practice models for EV therapies. Stem Cells Translational Medicine 2017;6:1730-1739.
Medical Subject Headings
Animals; Cell Transplantation; Congresses as Topic; Extracellular Vesicles; Humans; Practice Guidelines as Topic; Singapore; Translational Medical Research
PubMed ID
28714557
Volume
6
Issue
8
First Page
1730
Last Page
1739
